Clare Hughes, CEO of CF Pharma Group, has been named a finalist for the 2024 Ernst Young Entrepreneur of the Year Award. CF Pharma is a Kilkenny-based pharmaceutical lab that develops and manufactures veterinary medical devices and nutraceuticals for equine and livestock. Hughes is one of 24 nominees shortlisted for the award, with the overall winner to be announced at a gala ceremony later this month.
The nomination recognizes her leadership, entrepreneurial spirit, and significant contributions to growth and innovation in the nutraceutical industry. “I’m incredibly honoured to be recognised as a finalist for the EY Entrepreneur of the Year awards,” Hughes said.
Clare Hughes acknowledged for entrepreneurial leadership
“This nomination reflects the hard work and dedication of everyone at CF Pharma since our establishment in 2015. We are driven by a shared vision to improve global health outcomes, and it is truly humbling to have our efforts acknowledged in this way.”
The EY Entrepreneur of the Year awards celebrate leaders who have shown outstanding vision, resilience, and impact in their industries. As a finalist, Hughes joins an exclusive group of entrepreneurs who have made remarkable strides in creating sustainable businesses, driving innovation, and making a lasting impact on their sectors.
This year’s finalists were shortlisted from more than 200 nominations by an independent judging panel of previous winners. “Under Clare’s leadership, CF Pharma has experienced tremendous growth, advancing its mission to deliver high-quality, accessible nutraceutical products, medical devices, and novel health food supplements to animals and humans worldwide,” a CF Pharma spokesperson added. “Her commitment to fostering a culture of innovation, excellence, and ethical business practices has been central to the company’s success.”
